Bank Julius Baer & Co
NVO

Bank Julius Baer & Co’s Novo Nordisk NVO Stock Holding History

Bank Julius Baer & Co’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211K Buy
4,373
+3,000
+218% +$129K ﹤0.01% 501
2026
Q1 		$50.5K Sell
1,373
-2,693
-66% -$128K ﹤0.01% 599
2025
Q4 		$207K Buy
4,066
+2,693
+196% +$138K ﹤0.01% 484
2025
Q3 		$76.2K Hold
1,373
– – ﹤0.01% 560
2025
Q2 		$94.8K Buy
+1,373
New +$93.4K ﹤0.01% 501

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank Julius Baer & Co's NVO Position: Q2 2026 in Review

Bank Julius Baer & Co increased its Novo Nordisk (NVO) stake by 218% in Q2 2026, buying an estimated $129K and bringing the position to 4,373 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #501.

Bank Julius Baer & Co first reported a position in NVO in Q2 2025 and has held it in 5 quarters since. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Bank Julius Baer & Co held 4,373 shares of Novo Nordisk worth $211K as of Q2 2026.
  • Bank Julius Baer & Co bought 3,000 Novo Nordisk shares in Q2 2026, an estimated $129K.
  • Novo Nordisk made up ﹤0.01% of Bank Julius Baer & Co's portfolio in Q2 2026, its #501 holding.
  • Bank Julius Baer & Co first reported a position in Novo Nordisk in Q2 2025 and has held it in 5 quarters since.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Bank Julius Baer & Co's 13F filing for Q2 2026, filed 10 Aug 2026.